Reuters logo
BRIEF-Amgen does not expect Repatha outcomes data in label until 2018
January 9, 2017 / 10:52 PM / a year ago

BRIEF-Amgen does not expect Repatha outcomes data in label until 2018

Jan 9 (Reuters) - Amgen Inc

* Amgen says does not expect Repatha outcomes data to be in label until 2018

* Amgen says cannot promote any Repatha heart benefits from outcomes study until it included in label

* Amgen says still expects to report Repatha outcomes data at ACC scientific meeting in March Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below